What are the characteristics of the ischemia modified albumin assay kit

The ischemia modified albumin (IMA) assay kit has the characteristics of high sensitivity, strong specificity, good repeatability, convenient operation, diverse sample types, and good stability. The following is a detailed summary of its characteristics:

High sensitivity: it can accurately detect lower levels of IMA in the sample. For example, some test kits have a sensitivity of 0.1U/mL or lower, while others have a minimum detection concentration of less than 1.0ng/mL, which can meet the detection requirements for low concentration IMA. Strong specificity: The antibodies in the kit only have specific recognition ability for IMA and do not undergo significant cross reactivity with other soluble substances with similar structures, ensuring the accuracy of the detection results. Good repeatability: The intra - and inter batch coefficients of variation of pre packaged microplates are usually less than 10%, and some assay kits have intra plate coefficients of variation less than 10% and inter plate coefficients of variation less than 15%, which can ensure the repeatability of experimental results.

Easy to operate: Enzyme linked immunosorbent assay (ELISA) is used, usually in a double antibody sandwich mode, with clear experimental principles, relatively simple operating steps, and easy to master.

Diverse sample types: suitable for the detection of various liquid samples such as serum, plasma, tissue homogenate, cell supernatant, cell lysate, etc., providing convenience for different experimental needs.

Good stability: Under specified storage conditions (such as 2-8 ℃ in the dark), the reagent kit has a long shelf life, some up to 12 months, and also has a certain shelf life after opening, ensuring the stability of the reagent kit during storage and use.